Beyond label claims: Clinical trial findings paramount to meet consumers’ knowledge needs – Immunity Broadcast panel Clinical trial findings are becoming ever more important in today’s world as consumers are looking beyond label claims and are actively reading up on the health benefits and evidence of ingredients used in immunity products, according to an expert panel.
The panel discussed the topic “Immunity and Clinical Trials/ Emerging Research” during the first broadcast of the NutraIngredients Immunity Interactive Broadcast Series from APAC. (Listen on demand here)
Industry experts involved in the discussion included Dr Amanda Rao, founder and principal investigator at RDC Clinical, Dr Daisuke Fujiwara, deputy GM of the Health Science Department at major MNC Kirin, Dr Samuel JK Abraham, head of R&D at GN Corporation (Japan), Dr Rajen Manicka, CEO of ASX-listed biotech firm Holista Colltech, and Dr Priyali Shah, lead scientist at Tata NQ